KWS BioTest

Charles River buys KWS BioTest for $20M, gaining immunology discovery capacity and a UK footprint
Endpoints
Thu, 01/11/18 - 09:53 am
Charles River Laboratories
KWS BioTest
M&A
immunology
R&D